- ISIN
- CA05156X8843
- CUSIP
- 05156X884
- Sector
- Healthcare
- IPO Date
- Jul 11, 2014
Highlights
- Market Cap
- $164.94M
- Enterprise Value
- $106.30M
- EPS (TTM)
- -CA$1.33
- Total Revenue (TTM)
- CA$310.87M
- Gross Profit (TTM)
- CA$176.08M
- EBITDA (TTM)
- CA$10.48M
- Year Range
- $2.73 - $6.67
- Target Price
- $5.92
- ROA (TTM)
- -12.45%
- ROE (TTM)
- -14.62%
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
ACB Performance Chart
Aurora Cannabis Inc. (ACB) is down 32.0% since the beginning of the year. At $3 per share, ACB is trading 56.9% below its 52-week high of $7. Investors who bought $1,000 worth of ACB shares 5 years ago would now be looking at an investment worth $32.
Loading charts...
Returns By Period
Aurora Cannabis Inc. (ACB) has returned -31.99% so far this year and -29.66% over the past 12 months. Over the last ten years, ACB has returned -23.86% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.
Aurora Cannabis Inc.
- 1D
- -2.05%
- 1M
- -17.05%
- YTD
- -31.99%
- 6M
- -38.81%
- 1Y
- -29.66%
- 3Y*
- -19.55%
- 5Y*
- -49.82%
- 10Y*
- -23.86%
Benchmark (S&P 500 Index)
- 1D
- -0.37%
- 1M
- -0.01%
- YTD
- 9.16%
- 6M
- 8.64%
- 1Y
- 25.22%
- 3Y*
- 19.78%
- 5Y*
- 11.99%
- 10Y*
- 13.88%
ACB Monthly Returns History
Based on dividend-adjusted daily data since Jul 11, 2014, ACB's average daily return is +0.10%, while the average monthly return is +1.69%. At this rate, an investment would double in approximately 3.4 years.
Historically, 38% of months were positive and 62% were negative. The best month was Nov 2020 with a return of +188.4%, while the worst month was Jan 2015 at -57.7%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 10 months.
On a daily basis, ACB closed higher 41% of trading days. The best single day was Jul 11, 2014 with a return of +98.7%, while the worst single day was Jan 12, 2015 at -57.7%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -3.79% | -5.42% | -14.84% | 5.20% | 4.65% | -20.28% | -31.99% | ||||||
| 2025 | -14.12% | 39.73% | -13.92% | 5.69% | 14.22% | -20.00% | 4.48% | 22.35% | 9.96% | -16.95% | -7.07% | -8.26% | -0.71% |
| 2024 | -20.18% | -17.39% | 39.81% | 110.25% | -32.94% | -25.36% | 33.12% | -1.14% | -3.29% | -7.82% | -16.05% | -6.59% | -10.75% |
| 2023 | 12.72% | -19.71% | -16.49% | -13.95% | -15.18% | 5.05% | 5.26% | -14.66% | 21.82% | -24.56% | 4.24% | 3.52% | -48.38% |
| 2022 | -23.11% | -8.65% | 5.26% | -24.25% | -45.21% | -20.48% | 6.82% | 13.48% | -23.75% | 17.21% | -11.19% | -27.35% | -82.95% |
| 2021 | 34.18% | -5.65% | -11.50% | -3.97% | 8.05% | -6.42% | -22.35% | 5.70% | -6.74% | -4.19% | -3.17% | -15.73% | -34.90% |
Benchmark Metrics
Aurora Cannabis Inc. has an annualized alpha of 7.00%, beta of 1.35, and R2 of 0.05 versus S&P 500 Index. Calculated based on daily prices since July 11, 2014.
- This stock participated in 156.51% of S&P 500 Index downside but only 9.69% of its upside - more exposed to losses than it benefited from rallies.
- R2 of 0.05 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 7.00%
- Beta
- 1.35
- R²
- 0.05
- Upside Capture
- 9.69%
- Downside Capture
- 156.51%
Return for Risk
Risk / Return Rank
ACB ranks 23 for risk / return — below 23% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Aurora Cannabis Inc. (ACB) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ACB | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.49 | ||
| Sortino ratioReturn per unit of downside risk | -3.11 | ||
| Omega ratioGain probability vs. loss probability | 0.96 | 1.37 | -0.41 |
| Calmar ratioReturn relative to maximum drawdown | -0.55 | 2.78 | -3.34 |
| Martin ratioReturn relative to average drawdown | -0.94 | 12.44 | -13.38 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Aurora Cannabis Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Aurora Cannabis Inc. was 99.80%, occurring on Jun 22, 2026. The portfolio has not yet recovered.
The current Aurora Cannabis Inc. drawdown is 99.80%.
Related event | Drawdown | Fall | Recovery | Underwater |
|---|---|---|---|---|
2026 bear market2026 | -99.80%Jun 2026 | 8y 5mo | — | 8y 5moJan 2018 - now |
2015 bear market2015 | -78.02%Aug 2015 | 7mo 14d | 1y 27d | 1y 8moJan 2015 - Sep 2016 |
2014 bear market2014 | -50.55%Aug 2014 | 18d | 1mo 8d | 1mo 26dJul 2014 - Sep 2014 |
2017 bear market2017 | -39.39%Jun 2017 | 1mo 26d | 4mo 1d | 5mo 27dApr 2017 - Oct 2017 |
2016 bear market2016 | -36.61%Dec 2016 | 17d | 4mo 3d | 4mo 20dNov 2016 - Apr 2017 |
Drawdown Indicators
| ACB | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.80% | -56.78% | -43.02% |
Max Drawdown (1Y)Largest decline over 1 year | -53.93% | -9.10% | -44.83% |
Max Drawdown (3Y)Largest decline over 3 years | -70.80% | -18.90% | -51.90% |
Max Drawdown (5Y)Largest decline over 5 years | -96.93% | -25.43% | -71.50% |
Max Drawdown (10Y)Largest decline over 10 years | -99.80% | -33.92% | -65.88% |
Current DrawdownCurrent decline from peak | -99.80% | -1.80% | -98.00% |
Average DrawdownAverage peak-to-trough decline | -70.71% | -10.71% | -60.00% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 31.63% | 2.03% | +29.60% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Aurora Cannabis Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Aurora Cannabis Inc. is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for ACB relative to other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, ACB has a P/S ratio of 0.7. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for ACB in comparison with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, ACB has a P/B value of 0.5. This P/B ratio is low compared to industry peers. It might indicate the stock is undervalued or that the company’s assets are not expected to generate strong returns.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with ACB
Add Aurora Cannabis Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with ACB